Latest news with #FierceCROAwards
Yahoo
10 hours ago
- Business
- Yahoo
Lindus Health Named Fierce CRO Award Winner in the Outstanding Patient Recruitment and Retention Category
BOSTON, June 18, 2025 /PRNewswire/ -- Lindus Health, the anti-CRO running radically faster, more reliable clinical trials, has been honored the winner in the 2025 Fierce CRO Awards' Outstanding Patient Recruitment and Retention category, which celebrate exceptional achievements and innovations by Contract Research Organizations (CROs). These awards spotlight CROs that exemplify innovation, performance, and leadership in advancing life sciences research and improving patient outcomes. Lindus Health earned this recognition for its innovative use of the Patient Identification Center (PIC) technique, which leverages advanced algorithms and customized search protocols based on real-world medical record data to reduce screen fail rates and accelerate recruitment with greater precision. This approach was instrumental in its collaboration with Myota on a pre-diabetes trial, which achieved a 54% screening conversion rate—five times the industry benchmark—and completed enrollment in just four months. Backed by deep expertise in healthcare data, clinical systems, and physician behavior, Lindus Health's unique PIC approach stands out not just for using EHR-driven participant searches, but for how it executes them. While many CROs rely on medical practices to run standard queries, Lindus builds its own highly customized, in-house searches. These go beyond basic inclusion and exclusion criteria, incorporating a nuanced understanding of how data is actually recorded and coded by general practitioners. For example, when a trial sought patients with "reduced sexual desire," Lindus optimized results by using "low libido"—a term more commonly coded by GPs—significantly improving the ability to identify eligible participants. "Receiving the Fierce CRO Award is a tremendous honor," said Meri Beckwith, co-founder of Lindus Health. "It reflects our mission to fix the broken clinical trial model so patients can access treatments faster. With innovative strategies like our PIC technique, smart study design, and proprietary AI, we're delivering faster, more precise, and cost-effective trials—even in complex cases. Our work isn't done though, and we're continuing to push the boundaries of what's possible in clinical research, making it more efficient, inclusive, and patient-centric every step of the way." This award comes on the heels of Lindus Health's Series B funding round of $55 million, which is fueling strategic hiring across clinical operations and product development, while expanding the capabilities of its proprietary AI-powered eClinical platform, Citrus™. The investment is enabling advancements in study design optimization, automated central monitoring, and real-time biostatistics. As the only major service provider with a fully in-house platform, Lindus integrates all core clinical research technologies—including CTMS, EDC, eDiary, visit scheduling, and more—into a seamless, unified ecosystem. In partnership with Oxford University, Lindus Health published a study on diverse perceptions of clinical trial participation, helping to inform more inclusive and patient-centered research. Additionally, Lindus is collaborating with CDISC, the organization that sets clinical data standards for the FDA, to develop standardized templates for clinical observations and is contributing to ARIA's Safeguarded AI program to improve trial design through safer, more reliable AI. The full Fierce CRO Awards report profiling all winners is available here. Lindus Health's award-winning capabilities can be found at About Lindus Health Lindus Health is an anti-CRO running radically faster, more reliable clinical trials for life science pioneers – bringing ground-breaking treatments to patients more quickly. This is achieved through a commercial model that aligns incentives (fixed-priced quotes per study, with milestone-based payments), a world-class clinical operations team with its unique software platform, and access to over 40 million Electronic Health Records. Clinical trials are the biggest bottleneck to advances in healthcare. Lindus Health removes this constraint through end-to-end execution of clinical studies driven by technology and forward-thinking approaches to clinical operations. To date, Lindus Health has delivered clinical trials across the US, UK, and Europe to tackle a range of conditions, including diabetes, asthma, acne, social anxiety, major depressive disorder, hypertension, chronic fatigue syndrome and insomnia. The company has raised over $80M from investors including Peter Thiel, Balderton, Creandum, Firstminute Capital, and Seedcamp. About Fierce BiotechFierce Biotech is the biotech industry's daily monitor, providing the latest news, articles, and resources related to clinical trials, drug discovery, FDA approval, FDA regulation, patent news, pharma news, biotech company news and more. More than 300,000 top biotech professionals rely on Fierce Biotech for an insider briefing on the day's top stories. Signup is free here. Press contact: Jodi PerkinsAmendola Communications for Lindus HealthJperkins@ Cell: 847.508.0877 View original content to download multimedia: SOURCE Lindus Health
Yahoo
20-05-2025
- Business
- Yahoo
TrialWire the AI and Algorithm-powered Platform Named a Fierce CRO Award Finalist in the 'Outstanding Patient Recruitment and Retention' Category
TrialWire™ is the risk-share pay-per-enrolled AI and algorithm-powered patient recruitment Platform built on Salesforce Health Cloud for industry-leading patient data and IP security CRO Awards SAN FRANCISCO, May 20, 2025 (GLOBE NEWSWIRE) -- TrialWire today announces it was named a Fierce CRO Award finalist by Fierce Biotech in the Outstanding Patient Recruitment and Retention category. TrialWire is the AI and algorithm-powered patient-recruitment and enrollment platform, purpose-built on Salesforce Health Cloud to guarantee best-in-class data and IP security. The Platform is a risk share pay-per-enrolled patient offering that accelerates global studies across multiple languages and cultures as well as single country or regional studies, and hybrid decentralized trials. The Platform is specifically designed to rescue stalled trials with its lead product RapidRescue™. Pre-register your study here just in-case Sponsors and CROs who want recruitment certainty from startup can also leverage TrialWire's curated custom patient registry solution GeoClinical™ to boost enrollment from Site activation. TrialWire starts recruiting in under 24 hours and delivers, with complete HIPAA and GDPR compliance, across even the toughest therapeutic areas and protocols. More than 17,000 studies are now pre-registered on the Platform just in case they need a rapid patient recruitment boost. The Fierce CRO Awards celebrate exceptional achievements and innovations by Contract Research Organizations (CROs). These awards honor CROs that have demonstrated outstanding performance, innovation, and leadership in delivering high-quality research and development services. By recognizing the excellence of CROs, the awards aim to highlight the critical role they play in advancing life sciences research and improving patient outcomes. 'We are honored to be selected as one of only three global finalists in the Fierce Biotech CRO Awards for 'Outstanding Patient Recruitment and Retention',' said Director Susan Fitzpatrick-Napier. 'We are a young technology company designed to help Sponsors and Sites securely recruit and enroll smarter and faster, and to accelerate communications between Sites and patients to maximize retention. With more than 80% of trials delayed, and often fail, due to patient recruitment issues we are proud to be the go-to solution for some of the most challenging trials, especially in oncology, rare diseases, and CNS. Our recruitment team brings 10+ years of hands-on experience across hundreds of protocols and TAs, while our industry-leading Platform developers have uniquely optimized the experience for patients, Sites, Sponsors, and CROs - meeting the highest standards of data security. Thank you to our clients, partners, and the Fierce Biotech judges for this recognition.' The Fierce CRO Awards finalists were judged on: Innovation and Impact, Measurable Outcomes, Sustainability and Scalability and Ethical and Regulatory Adherence. Fierce CRO Awards winners will be announced on June 18. About is the leading digital patient recruitment Platform, purpose-built to address the biopharma challenges of clinical trial enrollment. TrialWire's RapidRescue™ solution combines advanced AI-driven technology, health algorithms, real-time communication tools, and robust data insights. TrialWire rapidly identifies, screens, and connects eligible participants to clinical trials, significantly reducing enrollment timelines and associated costs. The platform is built on Salesforce Health Cloud, ensuring the highest levels of security and compliance. More than 17,000 studies are now pre-registered just in case they need a rapid patient recruitment boost. Pre-register your study here just in-case About Fierce Biotech is the biotech industry's daily monitor, providing the latest news, articles, and resources related to clinical trials, drug discovery, FDA approval, FDA regulation, patent news, pharma news, biotech company news and more. More than 300,000 top biotech professionals rely on Fierce Biotech for an insider briefing on the day's top stories. Signup is free here. Media ContactDavid JamesMedia Advisor DMG AgencyTeam@ A photo accompanying this announcement is available at in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
14-05-2025
- Business
- Yahoo
Questex's Fierce Biotech Announces 2025 Fierce CRO Award Finalists
NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Questex's Fierce Biotech today announces the finalists of the second annual Fierce CRO Awards. The Fierce CRO Awards celebrate exceptional achievements and innovations by Contract Research Organizations (CROs). These awards honor CROs that have demonstrated outstanding performance, innovation, and leadership in delivering high-quality research and development services. By recognizing the excellence of CROs, the awards aim to highlight the critical role they play in advancing life sciences research and improving patient outcomes. Fierce CRO Award finalists include: CRO Champion Award Dr. Uma Sharma, Founder and CEO, MMS GenScript Biotech Corp Toyna Chin, Global Director of Marketing, Novotech Excellence in Client Service and Partnership CMIC Group MMS Navitas Life Sciences Excellence in Clinical Trial Management Phastar Clinical Intelligence by Phastar PSI CRO: The Leading CRO in Radiopharmaceutical Trial Management and Beyond by PSI CRO AG Trial Management Collaboration and Support for an Emerging Oncology Biotech by Catalyst Clinical Research Excellence in Global Operations CTI Clinical Trial & Consulting Excellence in Global Operations by Crown Bioscience TFS HealthScience Innovative Approaches to Patient-Centric Research CTI Clinical Trial & Consulting Empowering Patient-Centric Trials by IQVIA Patient-Centered Endpoints by Fortrea Innovative Solutions in Drug Development BioPALS Hit Identification by Concept Life Sciences Centralized Monitoring for Best-In-Class Data Management by Precision for Medicine CertisOI Assistant: The Digital Assistant for Oncology Research by Certis Oncology Solutions Outstanding Patient Recruitment and Retention Reinventing Patient Recruitment Approaches: Lindus Health's Novel Application of the Patient Identification Center (PIC) Technique by Lindus Health Patient recruitment and retention by Centre for Human Drug Research TrialWire 'Our awards program honors the outstanding performance, innovation and leadership of Contract Research Organizations in the life sciences industry. We applaud the award finalists on their work to advance research as well as the industry. We look forward to seeing who comes up on top in June,' said Rebecca Willumson, SVP and Publisher of Fierce Biotech and Fierce Pharma. The Fierce CRO Awards finalists were judged on: Innovation and Impact, Measurable Outcomes, Sustainability and Scalability and Ethical and Regulatory Adherence. Winners will be announced on June 18. About Fierce Biotech is the biotech industry's daily monitor, providing the latest news, articles, and resources related to clinical trials, drug discovery, FDA approval, FDA regulation, patent news, pharma news, biotech company news and more. More than 300,000 top biotech professionals rely on Fierce Biotech for an insider briefing on the day's top stories. Signup is free here. About QuestexQuestex helps people live better and longer. Questex brings people together in the markets that help people live better: hospitality and wellness; the industries that help people live longer: life science and healthcare; and the technologies that enable and fuel these new experiences. We live in the experience economy – connecting our ecosystem through live events, surrounded by data insights and digital communities. We deliver experience and real results. It happens here. Media ContactKathleen DeanFierce CRO Awardskdean@
